# clm_3DEAF95EF6B0

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 8,247,000,000 United States dollar  
valid_from: 2021-06-30  
valid_to: 2021-09-30  
published: 2021-08-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_6DC2B1698886  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 8,247,000,000 United States dollar", as of 2021-06-30 (until 2021-09-30). Claim clm_3DEAF95EF6B0, https://asof.is/claim/clm_3DEAF95EF6B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815421000034/0000318154-21-000034-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2021-08-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815421000034/0000318154-21-000034-index.htm (primary, SEC EDGAR 10-Q Q2 FY2021, published 2021-08-04)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 9,334,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_3DEAF95EF6B0](/claim/clm_3DEAF95EF6B0.md) | [clm_38D0C83AFC61](/claim/clm_38D0C83AFC61.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.